To further explore the role of WNT5A in liver cancer, we treated primary liver cancer cells with WNT5A, and found WNT5A treated cells showed enhanced Wnt/β-catenin activation (Fig. 6f). The gene discussed is WNT5A; the disease is liver cancer.